In addition, an inhibitor of STAT3 was able to inhibit the proliferation of HFD-induced thyroid cancer cells through the reduction of cyclins D1 and B1, CDK4, CDK6 and pRB (125). This evidence concerns the gene RB1 and thyroid gland carcinoma.